highly significantp = 8.8E-13
We observed that the tumor types with highly significant KDM7A-DT gain and amplification were highly aggressive, including hepatocellular carcinoma ( p = 8.8E-13), pilocytic astrocytoma ( p = 3.43E-10), melanoma ( p = 5.21E-10), prostate adenocarcinoma ( p = 5.16E-08), medulloblastoma ( p = 4.20E-07), and colorectal carcinoma ( p = 6.14E-04).